Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota
Open Access
Abstract
Enterohemorrhagic Escherichia coli (EHEC) serotype O157:H7 is a commonly encountered foodborne pathogen that can cause hemorrhagic enteritis and lead to hemolytic uremic syndrome (HUS) in severe cases. Bifidobacterium is a beneficial bacterium that naturally exists in the human gut and plays a vital role in maintaining a healthy balance in the gut microbiota. This study investigated the protective effects of B. longum K5 in a mouse model of EHEC O157:H7 infection. The results indicated that pretreatment with B. longum K5 mitigated the clinical symptoms of EHEC O157:H7 infection and attenuated the increase in myeloperoxidase (MPO) activity in the colon of the mice. In comparison to the model group, elevated serum D-lactic acid concentrations and diamine oxidase (DAO) levels were prevented in the K5-EHEC group of mice. The reduced mRNA expression of tight junction proteins (ZO-1, Occludin, and Claudin-1) and mucin MUC2, as well as the elevated expression of virulence factors Stx1A and Stx2A, was alleviated in the colon of both the K5-PBS and K5-EHEC groups. Additionally, the increase in the inflammatory cytokine levels of TNF-α and IL-1β was inhibited and the production of IL-4 and IL-10 was promoted in the K5-EHEC group compared with the model group. B. longum K5 significantly prevented the reduction in the abundance and diversity of mouse gut microorganisms induced by EHEC O157:H7 infection, including blocking the decrease in the relative abundance of Roseburia, Lactobacillus, and Oscillibacter. Meanwhile, the intervention with B. longum K5 promoted the production of acetic acid and butyric acid in the gut. This study provides insights into the use of B. longum K5 for developing probiotic formulations to prevent intestinal diseases caused by pathogenic bacterial infections.Keywords
Funding Information
- National Natural Science Foundation of China (32072190)
This publication has 55 references indexed in Scilit:
- Lactobacillus plantarum KLDS1.0386 with antioxidant capacity ameliorates the lipopolysaccharide-induced acute liver injury in mice by NF-κB and Nrf2 pathwayFood Bioscience, 2022
- Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Recent developments in probiotics: An emphasis on BifidobacteriumFood Bioscience, 2021
- The intervention effects of Lactobacillus casei LC2W on Escherichia coli O157:H7 -induced mouse colitisFood Science and Human Wellness, 2020
- Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human healthApplied Microbiology and Biotechnology, 2019
- Antagonistic activities of some Bifidobacterium sp. strains isolated from resident infant gastrointestinal microbiota on Gram-negative enteric pathogensAnaerobe, 2016
- Effect of Lactobacillus Strains on Intestinal Microflora and Mucosa Immunity in Escherichia coli O157:H7-Induced Diarrhea in MiceCurrent Microbiology, 2016
- Bacteriocin production by Bifidobacterium spp. A reviewBiotechnology Advances, 2013
- Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strainsAntonie van Leeuwenhoek, 2009
- The in vitro inhibition of Gram-negative pathogenic bacteria by bifidobacteria is caused by the production of organic acidsInternational Dairy Journal, 2006